Status:
COMPLETED
Risk Factors of Necrotizing Enterocolitis in Premature Newborns
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Necrotizing Enterocolitis of Newborn
Risk Factors
Eligibility:
All Genders
Brief Summary
With premature newborn increase survival, the risk of serious neonatal morbidity, such as necrotizing enterocolitis (NEC), also increased. NEC affects between 2 to 7% of premature infants including 5 ...
Eligibility Criteria
Inclusion
- Premature newborns (\< 37 weeks of gestation) having done a necrotizing enterocolitis stage II or III according to Bell's criteria.
Exclusion
- Children term born (\> 37 weeks of gestation)
- Necrotizing enterocolitis during an hospitalisation outside the NICU of Nancy or Lyon
- Malformation or pre-existing digestive pathology
- Complex or severe malformative pathologies
Key Trial Info
Start Date :
January 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
459 Patients enrolled
Trial Details
Trial ID
NCT04719546
Start Date
January 21 2021
End Date
August 31 2021
Last Update
March 4 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Maternite Regionale Universitaire CHRU NANCY
Nancy, Lorraine, France, 54035
2
CHU LYON
Bron, France, 69677